Skip to main content
OpenTrials
Completed

NCT Number: NCT06102096

Culturally Adapted iCBT for Arabic-speaking Refugee and Migrant Youth With Common Mental Health Problems

The aim of the current study is to explore whether culturally adapted internet-based cognitive behavioral therapy is effective in reducing the symptoms of various common mental health problems among Arabic-speaking refugee and migrant youth. We hypothesize that the symptoms of the psychological problems will significantly be reduced among youth who will receive iCBT compared to youth in the control group.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 15 and 29.
  • A score above the cut-off 1.75 on HSCL-25
  • Has a refugee or migrant background
  • Has a good and stable internet connection
  • Has access to a computer, a tablet or a smartphone
  • Is fluent in reading and writing Arabic
  • Has the ability to dedicate time to take part in the intervention for 6-10 weeks.

Exclusion criteria

  • Is suffering from a severe mental illness, such as psychosis or severe depression.
  • Is suffering from substance abuse
  • Is undergoing a psychological treatment
  • Has a high risk of suicide

Treatment and study plan

Culturally Adapted iCBT

Behavioral

A culturally adapted iCBT targeting mild to moderate mental health problems among Arabic-speaking refugee and migrant youth.

Primary outcomes

  1. HSCL-25

    Time frame: Pre-intervention, during the intervention, immediately after the intervention, 6 months after completion of the intervention

    Assessment of anxiety and depressive symptoms

Secondary outcomes

  1. PHQ-9

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    assessment of depressive symptoms

  2. PSYCHLOPS

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    Impact of problematic area on function

  3. ISI

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    Assessment of severity of insomnia

  4. PG-13

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    Assessment of prolonged grief disorder

  5. PCL-5

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    assessment of symptoms of post-traumatic stress disorder

  6. WHO-5

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    assessment of subjective psychological well-being

  7. BRS

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

    assessment of resilience

Other outcomes

  1. CSQ

    Time frame: immediately after the intervention, 6 months after completion of the intervention

    assessment of the levels of satisfaction of the participant with the intervention

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Collaborators

  • Linkoeping University

Registry information

Official study title

A Randomized Controlled Trial of a Culturally Adapted iCBT for Arabic-speaking Refugee Youth With Common Mental Health Problems

Acronym: RAHA

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Oct 26, 2023
Registry last updated
Dec 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.